Inaktiver Wert

Andere Sprachen Theseus Pharmaceuticals, Inc.

Aktien

A3C4XZ

US88369M1018

THRX

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Theseus Pharmaceuticals, Inc. Announces Board Resignations	14.02.
Theseus Pharmaceuticals Announces Closing of Tender Offer	14.02.
Theseus Pharmaceuticals, Inc.(NasdaqGS:THRX) dropped from NASDAQ Composite Index	14.02.
Concentra Biosciences, LLC completed the acquisition of Theseus Pharmaceuticals, Inc..	14.02.
Theseus Pharmaceuticals, Inc.(NasdaqGS:THRX) dropped from S&P TMI Index	08.02.
Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals	30.01.
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates DSKE, THRX, CONN	11.01.
THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX	31.12.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX, CONN	27.12.
Sector Update: Health Care Stocks Gain in Late Afternoon	22.12.
THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders	22.12.
Sector Update: Health Care Stocks Higher Friday Afternoon	22.12.
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right	22.12.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX	22.12.
Shareholder Alert: Ademi LLP investigates whether Theseus Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Concentra	22.12.
Sector Update: Health Care Stocks Mixed Premarket Friday	22.12.
Theseus Pharmaceuticals to be Acquired by Concentra Biosciences; Shares Rise Pre-Bell	22.12.
Theseus Pharmaceuticals, Inc. Announces Employment Termination of Timothy P. Clackson as Chief Executive Officer, Effective December 7, 2023	04.12.
Theseus Pharmaceuticals, Inc. Announces Management Changes	04.12.
Theseus Pharmaceuticals Receives Acquisition Offers From Foresite, OrbiMed, Concentra Biosciences	27.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Theseus Pharmaceuticals, Inc.

Aktien

A3C4XZ

US88369M1018

THRX

Andere Sprachen

Filter